Spondylitis

18 registered clinical trials studyying Spondylitis — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Proprio Spine Measurement Tool NCT07023393	Duke University	N/A
Recruiting	Fecal Microbiota Transplantation in Axial Spondyloarthritis NCT06451588	University Hospital of North Norway	Phase 2
Recruiting	axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis NCT06460805	NHS Greater Glasgow and Clyde	N/A
Unknown	The Living With a Long-Term Condition Study NCT06072287	King's College London	—
Recruiting	Gene Expression Profiles in Spinal Tuberculosis. NCT05610098	University of Cape Town	—
Unknown	Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis NCT05376189	Hasanuddin University	Phase 2 / Phase 3
Withdrawn	Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spin NCT05098431	Allina Health System	N/A
Unknown	Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial In NCT04062695	Charite University, Berlin, Germany	Phase 2
Enrolling By Invitation	Dose Responsiveness as a Measure of Clinical Effectiveness During Neuromonitored Spine Surgery NCT05110833	Allina Health System	—
Completed	Evaluation of Outcomes of Surgical Treatment for Nonspecific Infectious Spondylodiscitis Via Posterior Approac NCT07349602	Federal State Budgetary Organization, Federal Center for Traumatology, Orthopedics and Arthroplasty	N/A
Completed	Biologic National Registry NCT03793660	Dacima Consulting	—
Unknown	Burst Biologics Spinal Fusion Registry NCT03064802	Burst Biologics	—
Unknown	Protection of Autonomic Nervous System During Lower Spine Surgical Procedures: A Safety and Feasibility Study NCT02873182	Stanley Skinner	N/A
Unknown	A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis NCT02809781	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2 / Phase 3
Unknown	Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments NCT01642706	University Hospital, Montpellier	—
Completed	Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis NCT00936143	Gu Jieruo	Phase 4
Completed	Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery NCT00320619	National Heart, Lung, and Blood Institute (NHLBI)	N/A
Completed	Genetics of Ankylosing Spondylitis NCT00081562	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	—